Atropine Eye Drop Market, Global Outlook and Forecast 2023-2029

Atropine sulfate is an antimuscarinic agent used as a cycloplegic and mydriatic. The eye drops are used in the treatment of iritis and uveitis to immobilise the iris and ciliary muscle and to prevent or break down adhesions.

Since it is a powerful cycloplegic it is used in the determination of refraction in children below six years and children with convergent strabismus.
This report aims to provide a comprehensive presentation of the global market for Atropine Eye Drop, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Atropine Eye Drop. This report contains market size and forecasts of Atropine Eye Drop in global, including the following market information:
Global Atropine Eye Drop Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Atropine Eye Drop Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Atropine Eye Drop companies in 2022 (%)
The global Atropine Eye Drop market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
0.001 Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Atropine Eye Drop include Martindale Pharma?Ethypharm, Aspire Pharma Ltd, Bausch & Lomb U.K Limited and OSRX, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Atropine Eye Drop manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Atropine Eye Drop Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Atropine Eye Drop Market Segment Percentages, by Type, 2022 (%)
    0.001
    0.005
    0.01
Global Atropine Eye Drop Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Atropine Eye Drop Market Segment Percentages, by Application, 2022 (%)
    Hospital
    Ophthalmic Clinic
    Pharmacy
    Others
Global Atropine Eye Drop Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Atropine Eye Drop Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Atropine Eye Drop revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Atropine Eye Drop revenues share in global market, 2022 (%)
Key companies Atropine Eye Drop sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Atropine Eye Drop sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Martindale Pharma?Ethypharm
    Aspire Pharma Ltd
    Bausch & Lomb U.K Limited
    OSRX
Outline of Major Chapters:
Chapter 1: Introduces the definition of Atropine Eye Drop, market overview.
Chapter 2: Global Atropine Eye Drop market size in revenue and volume.
Chapter 3: Detailed analysis of Atropine Eye Drop manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Atropine Eye Drop in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Atropine Eye Drop capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.